PD-1 Inhibitor Clinical Trials in Huizhou, Guangdong

1 recruitingHuizhou, Guangdong, China

Filters

Status

RecruitingNot yet recruitingEnrolling by invitationActive, not recruiting

Sex

MaleFemale

Your Age

Shows trials you qualify for by age

Phase

Phase 1Phase 2Phase 3Phase 4Early Phase 1Not Applicable

Study Type

InterventionalObservational

Country

United StatesCanadaUnited KingdomAustraliaGermanyFranceSpainItaly

Other Locations

Tianjin, Outside U.S.3
Chengdu, Sichuan2
Hangzhou, Zhejiang1
Xi'an, Shaanxi1
Beijing, Beijing Municipality1
Xi’an, Shanxi1
Haikou, Hainan1
Zhuhai, Guangdong1
Zhangzhou, Fujian1
Xiamen, Fujian1

Showing 1–1 of 1 trials

Recruiting

Phase 1Phase 2

Intrathecal Dual Checkpoint Inhibitor (PD-1 and CTLA-4) in Combination With Pemetrexed for Leptomeningeal Metastasis

Solid TumorsLeptomeningeal MetastasisCTLA4+2 more

Guangzhou Medical University34 enrolled2 locationsNCT06809530

ClinicalTrialsFinder

Helping patients and researchers find recruiting clinical trials. Updated regularly from ClinicalTrials.gov and ANZCTR.

Browse

Browse Conditions
Browse Drugs
Browse Locations
Browse Institutions
Search Trials
Get Trial Alerts

Resources

Clinical Trial Guides
FAQ
About Us
Contact
ClinicalTrials.gov
ANZCTR

Data Source

Trial data sourced from ClinicalTrials.gov and ANZCTR (Australian New Zealand Clinical Trials Registry)

Updated regularly to reflect the latest trial information

Medical Disclaimer: This site is for informational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before making decisions about participating in a clinical trial. Trial information may change; verify details directly with the trial sponsor or at the relevant registry (ClinicalTrials.gov or ANZCTR).

|

Privacy Policy Terms of Service

Data provided by ClinicalTrials.gov & ANZCTR